Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pathologic Complete Response × Dexamethasone × 90 days × Clear all

Sponsor

Conditions

Multiple Myeloma 110 Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Recurrence 15 Burkitt Lymphoma 11 Neoplasms, Plasma Cell 8 Neoplasms 8 Immunoglobulin Light-chain Amyloidosis 8 Prostatic Neoplasms 6 Neoplasm Metastasis 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasm, Residual 4 Lung Neoplasms 4 Leukemia, Biphenotypic, Acute 4 Carcinoma, Non-Small-Cell Lung 4 Paraproteinemias 3 Lymphoma, Mantle-Cell 3 Lymphoma, B-Cell 3 Lymphoma 3 Leukemia 3 Breast Neoplasms 3 Brain Neoplasms 3 Triple Negative Breast Neoplasms 2 Renal Insufficiency 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Hodgkin Disease 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2

Interventions

pembrolizumab 2 durvalumab 2 Standard of Care 2 Paclitaxel 2 Oxaliplatin 2 Irinotecan 2 Chemoradiotherapy 2 Carboplatin 2 Capecitabine 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 trebananib 1 trastuzumab duocarmazine 1 tislelizumab 1 tegafur-gimeracil-oteracil 1 talazoparib 1 sarilumab 1 relugolix 1 regorafenib 1 pexidartinib 1 pertuzumab 1 patritumab 1 olaparib 1 niraparib 1 neratinib 1 ganitumab 1 enzalutamide 1 dostarlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡